Yeva Margaryan

Yeva Margaryan: Meet the Experts of VIRO 2025

The Global Voices in Renal Oncology (VIRO) Virtual Congress, organized by OncoDaily, will be held on September 11–12, 2025. Chaired by Dr. Rana R. McKay with co-chair Dr. Yüksel Ürün, this year’s program will feature around 50 leading experts in renal oncology from across the globe, sharing cutting-edge updates and future perspectives.

  • The congress is free to attend.
  • Register via the link.

Co-Chair of VIRO

ImagesName
Rana McKay -OncoDaily

Rana McKay

Professor of Medicine and Urology at UC San Diego Health Co-leader of the GU Oncology Program at Moores Cancer Center

As Co-Chair of VIRO, Dr. Rana McKay (University of California, San Diego) opened the congress with her talk on
 “Future Directions: Emerging Agents and Combinations.”

She emphasized the momentum in renal cell carcinoma (RCC) research, highlighting how novel immunotherapies, targeted drugs, and rational combination strategies are reshaping patient care. Dr. McKay underscored the importance of personalized, biomarker-driven approaches and global collaboration, aiming to optimize survival and quality of life worldwide.

Spotlight on Yeva Margaryan

Yeva Margaryan is a Managing Editor of CancerWorld Magazine․

At the Global Voices in Renal Oncology (VIRO) Virtual Congress 2025, Yeva Margaryan will present on “CancerWorld: Honoring the Legacy and Moving Forward.” Her presentation will cover:

  • Overview of Cancer World’s history, mission, and evolution
  • Editorial team, leadership, and global contributions to oncology
  • Content formats and impactful coverage in the oncology field
  • Future plans and growth in digital presence and engagement

Global Voices in Renal Oncology (VIRO) 2025

Yeva Margaryan